MODIFICATION
66 -- ZEISS AXIOVERT 200 INVERTED MICROSCOPE
- Notice Date
- 8/25/2005
- Notice Type
- Modification
- NAICS
- 333314
— Optical Instrument and Lens Manufacturing
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, MD, 20857-0001
- ZIP Code
- 20857-0001
- Solicitation Number
- HHSF223200510238P-1003239
- Response Due
- 9/5/2005
- Archive Date
- 9/20/2005
- Point of Contact
- Alice Pagán, Contract Specialist, Phone (301) 827-7104, Fax (301) 827-7101, - Elizabeth Osinski, Contracting Officer , Phone 301-827-7043, Fax 301-827-7101,
- E-Mail Address
-
APagan@oc.fda.gov, elizabeth.osinski@fda.hhs.gov
- Small Business Set-Aside
- Total Small Business
- Description
- This Amendment is to notify that a List of Items will NOT be posted. Please disregard the following sentence included in the original synopsis: (PLEASE SEE ATTACHED LIST OF ITEMS). The Food and Drug Administration intends to award a Purchase Order on a sole source basis to HITECH INSTRUMENTS, INC., 855 SUSSEX BOULEVARD, BROOMALL, PA 19008-4310. The capabilities and features of ZEISS AXIOVERT 200 INVERTED MICROSCOPE are essential. This microscope has the required functions that are highly important for our research: 1. One of our requirements is the ability to perform at least qualitative polarimetry on specimens—with reflected and transmitted light. The Zeiss microscope incorporates Enhanced-Contrast Epiplan Neofluar objectives which are strain-free, i.e., do not introduce bias to the intensity of observed birefringence [contrast change from strain-induced polarization]. 2. In addition to the well-recognized mechanical stability of their platform and stage, Zeiss has incorporated a proprietary “planetary focus” mechanism in their focus drive. This becomes important because much of our specimen imaging will be at higher magnifica-tions (with correspondingly shallower depth of focus), where higher-accuracy and precision focusing is essential. 3. For highlighting defects in translucent-to-transparent specimens, we will be using a technique called Differential Interference Contrast (DIC). The Axiovert 200 incorporates a proprietary enhancement: Circular DIC, enabling structures in various orientations to be visualized simultaneously. 4. Because of the built-in features ordered with the Axiovert 200, at a later time we can upgrade the system to permit Circular Total Interference Contrast. This technology will allow sample step heights (z-axis) to be resolved in the nanometer range—a significant enhancement over conventional Mireau interferometry. An award will be made in ten (10) days from the date of this notice. This is not a request for quotes; however, sources may submit descriptive literature, which fully demonstrates their capabilities, which will be considered by the agency. This sole source procurement will be awarded as a simplified acquisition in accordance with FAR Subpart 13.5. NOTE: THIS NOTICE WAS NOT POSTED TO WWW.FEDBIZOPPS.GOV ON THE DATE INDICATED IN THE NOTICE ITSELF (25-AUG-2005); HOWEVER, IT DID APPEAR IN THE FEDBIZOPPS FTP FEED ON THIS DATE. PLEASE CONTACT fbo.support@gsa.gov REGARDING THIS ISSUE.
- Web Link
-
Link to FedBizOpps document.
(http://www.eps.gov/spg/HHS/FDA/DCASC/HHSF223200510238P-1003239/listing.html)
- Place of Performance
- Address: FDA/CDRH/OSEL/DCMS 12725 TWINBROOK PARKWAY ROCKVILLE, MD
- Zip Code: 20857
- Country: USA
- Zip Code: 20857
- Record
- SN00880100-F 20050827/050825213723 (fbodaily.com)
- Source
-
FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |